Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Trends in Gestational Diabetes Identified through Universal Screening: A Population-Based Observational Study.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Age- and cognitive load-related variability and entropy of gait: integrating coefficient of variation, median absolute deviation, and permutation entropy of spatiotemporal parameters into the Semmelweis Study gait assessment framework.

GeroScience·2026
Same author

Longitudinal associations of long-term exposure to ambient air pollution, residential greenness, and air temperature with type 2 diabetes subphenotypes: Results from the KORA cohort study.

Environment international·2026
Same author

Changes of the cardiac electrical cycle in type 1 diabetes during hypoglycaemia - a prospective observational study.

Frontiers in endocrinology·2026
Same author

Circulating Neutrophil and Monocyte Counts Are Inversely Associated With Heart Rate Variability Indices: The Maastricht Study.

Journal of the American Heart Association·2026
Same author

Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study).

BMJ open diabetes research & care·2026

関連する実験動画

Updated: May 21, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

前糖尿病:糖尿病を発症するリスクが高い状態.

Adam G Tabák1, Christian Herder, Wolfgang Rathmann

  • 1Department of Epidemiology and Public Health, University College London, London, UK. a.tabak@ucl.ac.uk

Lancet (London, England)
|June 12, 2012
PubMed
まとめ

糖尿病のリスクが高い状態である前糖尿病は,世界中で何百万人もの人に影響しています. ライフスタイルの変化による早期介入は,糖尿病の進行リスクを大幅に減らすことができます.

科学分野:

  • エンドクリノロジー エンドクリノロジー
  • メタボリック疾患
  • 公衆衛生は公衆衛生である.

背景:

  • 糖尿病前症候群または中間性高血糖症は,糖尿病の値を下回る高血糖値を意味する.
  • 大規模で増加する世界の人口に影響を及ぼし,2030年までに4億7000万人を超えると予測されています.
  • 糖尿病前症候群は,検出可能なグルコースの変化に先立って,インスリン抵抗性やベータ細胞機能不全が根底にあることが特徴です.

研究 の 目的:

  • 糖尿病前症候群に関する現在の理解をレビューする.
  • 関連する健康リスクと潜在的なリスク層分化戦略を強調する.
  • 証拠に基づいた予防と管理のアプローチを強調する.

主な方法:

  • 糖尿病前症候群と様々な合併症を結びつける観察的証拠のレビュー.
  • 糖尿病の予測のための多因子リスクスコアに関する議論.
  • ライフスタイルの変更と予防のための薬剤療法に関するデータの合成.

主要な成果:

  • 前糖尿病は,早期の腎不全,神経不全,網膜不全,およびマクロ血管疾患と関連しています.
  • 多因子リスクスコアは,糖尿病前の個体における糖尿病リスクの推定を改善することができます.

さらに関連する動画

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature

Published on: December 26, 2017

関連する実験動画

Last Updated: May 21, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature

Published on: December 26, 2017

  • ライフスタイルの変更により,糖尿病の進行に対する相対的なリスクが40~70%減少します.
  • 結論:

    • 糖尿病前症候群は,積極的な管理を必要とする重要な公衆衛生上の問題です.
    • 早期発見と介入,特にライフスタイルの変化は,糖尿病の予防に不可欠です.
    • 薬剤療法は,前糖尿病の管理に追加的な利点を提供することができます.